3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
50
Carcinoma, Non-Small-Cell Lung
26
Squamous Cell Carcinoma of Head and Neck
25
Head and Neck Neoplasms
12
Neoplasm Metastasis
11
Neoplasms
10
Colonic Neoplasms
10
Rectal Neoplasms
9
Pancreatic Neoplasms
9
Lung Neoplasms
9
Mouth Neoplasms
6
Carcinoma, Squamous Cell
6
Carcinoma
6
Laryngeal Neoplasms
5
Hypopharyngeal Neoplasms
5
Oropharyngeal Neoplasms
4
Thyroid Neoplasms
3
Solid Tumors
3
Ovarian Neoplasms
3
Gastrointestinal Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Pancreatic Ductal
3
Breast Neoplasms
3
Sarcoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Laryngeal Diseases
2
mCRC
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
Temozolomide
40
Magnetic Resonance Spectroscopy
19
Radiotherapy
18
Specimen Handling
14
Radiation
12
Bevacizumab
11
Lomustine
9
pembrolizumab
6
fludarabine
5
Surgical Procedures, Operative
5
atezolizumab
4
Nivolumab
4
Ipilimumab
4
Cyclophosphamide
4
Carboplatin
4
Biopsy
4
cemiplimab
3
azeliragon
3
Immunoglobulin G
3
Disulfides
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
rocakinogene sifuplasmid
2
poly ICLC
2
olaparib
2
lutetium Lu 177 dotatate
2
durvalumab
2
dabrafenib
2
contrast agent BR1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Cetuximab
×
90 days
×
Clear all
No trials found.